ITIH1 and Impaired glucose tolerance: Inter-alpha-trypsin inhibitor heavy chain H1 (ITIH1) is increased in human subjects with impaired glucose tolerance or diabetes and antibody neutralization of ITIH1 ameliorates systemic insulin resistance in mice20.